Development of Wheatgrass (Triticum aestivum) Extract Loaded Solid Lipid Nanoparticles using Central Composite Design and its Characterization- Its In-vitro Anti-cancer Activity


如何引用文章

全文:

详细

Background:The prevalence of cancer is around the world and is identified as a multifactorial ailment. One of the most common causes of cancer in the world is oxidative stress, and this can be overcome by taking herbal plant wheatgrass in any form. As colloidal carriers with particle sizes of 50-1,000nm, Solid Lipid Nanoparticles (SLNs) combine the benefits of liposomes, emulsions, and other colloidal systems to deliver drugs at their targets.

Objective:Aim and objective of the present work is to formulate wheatgrass extract loaded solid lipid nanoparticles using Central Composite design and to investigate the effect of formulation variables. Using hot homoginization method, the present work aimed to formulate wheatgrass loaded chitosan solid lipid nanoparticles using central composite design and to evaluate the extract potential to treat breast cancer on MCF-7 cell line.

Methods:This study investigated the effect of three formulation variables on particle size, namely the sodium alginate concentration, the calcium carbonate concentration, and the homogination time. Extraction of wheatgrass was done in soxhlet extractor, using methanolic extract. The hot homogenization technique was used to prepare Triticum aestivum extract loaded solid lipid nanoparticles (SLNs).

Result:For CCD, all formulations were analyzed for particle size, which ranged from 362.5 to 933.8 nm, and for polydispersity index, which ranged from 0.137 to 5.799. Batch code SLN-6 was found to be finest suitable because of maximum loading capacity of 67.76 ±0.17 % (w/w), maximum entrapment efficiency of 65.81 ± 0.11 % (w/w) and minimum particle size of 362.5nm by using sodium alginate as surface stabilizer at homogenization time ~ 5 min and having maximum percentage yield of 43.66%.

Conclusion:During characterization studies and MCF-6 cell line studies, it was found that batch code SLN-6 was found to be finest suitable and wheatgrass has anti-oxidant potential, and potent against breast cancer.

作者简介

Neha Minocha

Faculty of Pharmaceutical Sciences, Baba Mastnath University

编辑信件的主要联系方式.
Email: info@benthamscience.net

Parijat Pandey

Department of Pharmaceutical Sciences,, Gurugram University

Email: info@benthamscience.net

Nidhi Sharma

, D.J. College of Pharmacy

Email: info@benthamscience.net

Sangita Saini

Faculty of Pharmaceutical Sciences, Baba Mastnath University

Email: info@benthamscience.net

参考

  1. Rajagopalan R, Shakya G, Balasubramanian S. Methanol extract of wheatgrass induces G1 cell cycle arrest in a p53-dependent manner and down regulates the expression of cyclin D1 in human laryngeal cancer cells-an in vitro and in silico approach. Pharmacogn Mag 2015; 11(42): 139. doi: 10.4103/0973-1296.157715 PMID: 26109759
  2. Loizzo MR, Said A, Tundis R, et al. Antioxidant and antiproliferative activity of Diospyros lotus L. extract and isolated compounds. Plant Foods Hum Nutr 2009; 64(4): 264-70. doi: 10.1007/s11130-009-0133-0 PMID: 19731038
  3. Minocha N, Saini S, Pandey P. Nutritional prospects of wheatgrass (Triticum aestivum) and its effects in treatment and chemoprevention. Explor Med 2022; 3: 432-42. doi: 10.37349/emed.2022.00104
  4. Clement YN, Mahase V, Jagroop A, et al. Herbal remedies and functional foods used by cancer patients attending specialty oncology clinics in Trinidad. BMC Complement Altern Med 2016; 16(1): 399. doi: 10.1186/s12906-016-1380-x PMID: 27769229
  5. Kumar V, Minocha N, Garg V, Dureja H. Nanostructured materials used in drug delivery. Mater Today Proc 2022; 69(2): 174-80. doi: 10.1016/j.matpr.2022.08.306
  6. Minocha N, Kumar V. Nanostructure system: Liposome – A bioactive carrier in drug delivery systems. Mater Today Proc 2022; 69(2): 614-9. doi: 10.1016/j.matpr.2022.09.494
  7. Pandey P, Purohit D, Sharma S, et al. Nanocrystals: A deep insight into formulation aspects, stabilization strategies, and biomedical applications. Recent Pat Nanotechnol 2023; 17(4): 307-26. doi: 10.2174/1872210516666220523120313 PMID: 35616680
  8. Minocha N, Sharma N, Verma R, Kaushik D, Pandey P. Solid lipid nanoparticles: Peculiar strategy to deliver bio-proactive molecules. Recent Pat Nanotechnol 2023; 17(3): 228-42.
  9. Minocha N, Sharma N, Pandey P. Wheatgrass: An epitome of nutritional value. Curr Nutr Food Sci 2022; 18(1): 22-30. doi: 10.2174/1573401317666210906140834
  10. Pandey P, Chellappan DK, Tambuwala MM, Bakshi HA, Dua K, Dureja H. Central composite designed formulation, characterization and in vitro cytotoxic effect of erlotinib loaded chitosan nanoparticulate system. Int J Biol Macromol 2019; 141: 596-610. doi: 10.1016/j.ijbiomac.2019.09.023 PMID: 31494160
  11. Ilium L. Chitosan and its use as a pharmaceutical excipient. Pharm Res 1998; 15(9): 1326-31. doi: 10.1023/A:1011929016601 PMID: 9755881
  12. Minocha N, Sharma N, Pandey P, Saini S. Formulation and evaluation of solid lipid nanoparticles of wheatgrass (triticum aestivum) extract. Neuroquantology 2022; 20(17): 51.
  13. Vijayanand P, Jyothi V, Aditya N, Mounika A. Development and characterization of solid lipid nanoparticles containing herbal extract: In vivo antidepressant activity. J Drug Deliv 2018; 2018: 1-7. doi: 10.1155/2018/2908626 PMID: 29973993
  14. Das P, Kumar K, Nambiraj A, et al. Potential therapeutic activity of phlogacanthus thyrsiformis hardow (Mabb) flower extract and its biofabricated silver nanoparticles against chemically induced urolithiasis in male Wistar rats. Int J Biol Macromol 2017; 103: 621-9. doi: 10.1016/j.ijbiomac.2017.05.096 PMID: 28528955
  15. Madan JR, Ghuge NP, Dua K. Formulation and evaluation of proniosomes containing lornoxicam. Drug Deliv Transl Res 2016; 6(5): 511-8. doi: 10.1007/s13346-016-0296-9 PMID: 27255375
  16. Madan J, Adokar B, Dua K. Development and evaluation of in situ gel of pregabalin. Int J Pharm Investig 2015; 5(4): 226-33. doi: 10.4103/2230-973X.167686 PMID: 26682193
  17. Pandey P, Marwaha RK, Nanda A, Dureja H. Spray-dried nanoparticles-in microparticles system (NiMS) of acetazolamide using central composite design. Nanosci Nanotechnol Asia 2016; 6(2): 146-56. doi: 10.2174/2210681206666160402004241
  18. Elzoghby AO, Samy WM, Elgindy NA. Novel spray-dried genipincrosslinked casein nanoparticles for prolonged release of alfuzosin hydrochloride. Pharm Res 2013; 30(2): 512-22. doi: 10.1007/s11095-012-0897-z PMID: 23135815
  19. Kouhbanani MAJ, Beheshtkhoo N, Fotoohiardakani G, Hosseini-Nave H, Taghizadeh S, Amani AM. Green synthesis and characterization of spherical structure silver nanoparticles using wheatgrass extract. J Environ Treat Tech 2019; 7(1): 142-9.
  20. Patel P. Preformulation studies: An integral part of formulation design. In: Pharmaceutical Formulation Design-Recent Practices. IntechOpen 2019.
  21. Harivardhan Reddy L, Murthy RSR, Murthy RSR. Etoposideloaded nanoparticles made from glyceride lipids: Formulation, characterization, in vitro drug release, and stability evaluation. AAPS PharmSciTech 2005; 6(2): E158-66. doi: 10.1208/pt060224 PMID: 16353973
  22. Gorajana A, Kit W, Dua K. Characterization and solubility study of norfloxacin-polyethylene glycol, polyvinylpyrrolidone and carbopol 974p solid dispersions. Recent Pat Drug Deliv Formul 2015; 9(2): 167-82. doi: 10.2174/1872211309666150225124424 PMID: 25714525
  23. Sharma S, Ali A, Ali J, Sahni JK, Baboota S. Rutin: therapeutic potential and recent advances in drug delivery. Expert Opin Investig Drugs 2013; 22(8): 1063-79. doi: 10.1517/13543784.2013.805744 PMID: 23795677
  24. Chauhan M, Joshi G, Kler H, et al. Dual inhibitors of epidermal growth factor receptor and topoisomerase IIα derived from a quinoline scaffold. RSC Advances 2016; 6(81): 77717-34. doi: 10.1039/C6RA15118C
  25. Joshi G, Nayyar H, Kalra S, et al. Pyrimidine containing epidermal growth factor receptor kinase inhibitors: Synthesis and biological evaluation. Chem Biol Drug Des 2017; 90(5): 995-1006. doi: 10.1111/cbdd.13027 PMID: 28544624
  26. Dua K. Application of model independent approach on in vitro release of extemporaneously prepared semisolid formulations containing metronidazole with marketed silver sulfadiazine 1% cream, USP: a comparative investigation. Bull Pharm Res 2013; 3(1): 1-5.
  27. FDA,. Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms (BP1). Rockville, MD: Centre for Drug Evaluation and Research, Food and drug administration 1997; p. 9.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bentham Science Publishers, 2024